Our group developed an antibody against the above-mentioned epitope in CD147, and demonstrated reduced tumor growth in two subcutaneous models of colon and renal cell carcinomas, and reduced metastasis in an orthotopic model of 4T1 mammary gland cancer (98). This evidence concerns the gene BSG and neoplasm.